9 METERS BIOPHARMA, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | -.--% |
|
-.--% | -.--% |
| Mar. 25 | North American Morning Briefing : Tech in Focus on -2- | DJ |
| 2023 | Bidding Procedure Approved for 9 Meters Biopharma, Inc. | CI |
Financials (USD)
| Sales 2021 | - | Sales 2022 | - | Capitalization | 16.32M |
|---|---|---|---|---|---|
| Net income 2021 | -36M | Net income 2022 | -43M | EV / Sales 2021 | - |
| Net cash position 2021 | 46.83M | Net Debt 2022 | 7.08M | EV / Sales 2022 | - |
| P/E ratio 2021 |
-6.47
x | P/E ratio 2022 |
-0.37
x | Employees | 10 |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 98.29% |
More Fundamentals
* Assessed data
More news
More recommendations
More press releases
1 month
0.00
0.00
Current year
0.000.00
1 year
0.000.71
3 years
0.0029.20
5 years
0.0045.20
10 years
0.001 010.00
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-26 | 0.000001 | -.--% | 310 |
| 24-06-25 | 0.000001 | -.--% | 1,600 |
Delayed Quote OTC Markets, June 26, 2024 at 01:27 pm EDT
More quotes
9 Meters Biopharma, Inc. has ceased operations. The Company has filed a voluntary petition for relief under provisions of Chapter 7 of Title 11 of the United States Code (the Bankruptcy Code) in the United States Bankruptcy Court for the Eastern District of North Carolina.
Sector
Investment Holding Companies
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 14 | |
| +81.31% | 5.61B | |
| +94.72% | 1.23B | |
| +2.57% | 986M | |
| +29.44% | 846M | |
| +2.30% | 668M | |
| +1.44% | 615M | |
| -.--% | 600M | |
| +10.28% | 536M | |
| -.--% | 500M |
- Stock Market
- Equities
- NMTRQ Stock
